CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Cash flows from operating activities:
Net income ( loss)	$ 9,543	$ (17,084)	$ (31,640)
Loss from discontinued operations	10,109	15,227	26,108
Income (loss) from continuing operations	19,652	(1,857)	(5,532)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	126	222	323
Gain on settlement of pre-petition liabilities	(1,331)	0	0
Gain on sale of certain assets	(17,714)	0	0
Loss on disposal of property and equipment	164	0	0
Provision (recovery) for doubtful accounts	7	(93)	254
Share-based compensation	21	32	948
Impairment of investment securities	0	0	3,578
Loss on sale of investment securities	0	910	1,616
Changes in operating assets and liabilities:
Accounts receivable	1,742	(296)	1,249
Income taxes receivable	0	26	3,976
Prepaid expenses and other current assets	851	(150)	536
Other assets - net	(84)	7	2,224
Due to licensors	(546)	(704)	(2,192)
Accounts payable and accrued expenses	1,302	2,082	(456)
Liabilities subject to compromise	(5,218)	7,507	0
Deferred revenue	(2)	(1,035)	(217)
Increase (Decrease) in Deferred rent	0	0	0
Net cash (used in) provided by continuing operating activities	(1,030)	6,651	6,307
Net cash used in discontinued operating activities	(5,602)	(15,485)	(12,446)
Net cash used in operating activities	(6,632)	(8,834)	(6,139)
Cash flows from investing activities:
Proceeds from sale of investments	0	6,216	7,091
Proceeds from sale of certain assets	13,997	0	0
Purchase of property and equipment	0	(2)	(146)
Proceeds from disposal of property and equipment	0	25	30
Net cash provided by continuing investing activities	13,997	6,239	6,975
Net cash used in discontinued investing activities	0	0	(163)
Net cash provided by investing activities	13,997	6,239	6,812
Cash flows from financing activities:
Purchase of treasury shares	0	0	(54)
Capital contribution from noncontrolling interests	0	0	10
Net cash used in financing activities	0	0	(44)
Effects of exchange rate changes on cash and cash equivalents	19	27	(55)
Net increase (decrease) in cash and cash equivalents	7,384	(2,568)	574
Cash and cash equivalents, beginning of period	1,627	4,195	3,621
Cash and cash equivalents, end of period	9,011	1,627	4,195
Supplemental schedule of non-cash investing and financing activities
Unrealized gain on marketable securities included in other comprehensive loss	0	0	5,231
Vesting of restricted shares	88	738	1,711
In conjunction with the sale of certain of the Company's assets pursuant to the Asset Purchase Agreement
Other assets - continuing, acquired by buyers	1,596	0	0
Film costs, accounts receivable, other assets - discontinued, acquired by buyers	2,329	0	0
Accounts payable and accrued expense assumed by buyers	$ 6,642	$ 0	$ 0